| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |